![Quan Zhou Jiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Quan Zhou Jiang
Investor Relations Contact chez Zhejiang Heze Pharmaceutical Technology Co., Ltd.
Profil
Quan Zhou Jiang is currently the Board Secretary at Zhejiang Heze Pharmaceutical Technology Co., Ltd.
He previously worked as the Chief Financial Officer, Secretary & Director at Wanbangde Pharmaceutical Holding Group Co., Ltd.
from 2017 to 2020.
Prior to that, he held the position of Board Secretary & Deputy General Manager at Zhejiang Runtu Co., Ltd.
Postes actifs de Quan Zhou Jiang
Sociétés | Poste | Début |
---|---|---|
Zhejiang Heze Pharmaceutical Technology Co., Ltd.
![]() Zhejiang Heze Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Heze Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine. It offers generic drug development, consistency evaluation of generic drugs, pharmaceutical research and innovative drug development, and clinical trial services. The company was founded on October 27, 2006 and is headquartered in Hangzhou, China. | Investor Relations Contact | 30/09/2020 |
Anciens postes connus de Quan Zhou Jiang
Sociétés | Poste | Fin |
---|---|---|
WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. | Directeur Financier/CFO | 09/03/2020 |
ZHEJIANG RUNTU CO., LTD. | Secrétaire Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. | Health Technology |
ZHEJIANG RUNTU CO., LTD. | Process Industries |
Entreprise privées | 1 |
---|---|
Zhejiang Heze Pharmaceutical Technology Co., Ltd.
![]() Zhejiang Heze Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Heze Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine. It offers generic drug development, consistency evaluation of generic drugs, pharmaceutical research and innovative drug development, and clinical trial services. The company was founded on October 27, 2006 and is headquartered in Hangzhou, China. | Commercial Services |